US1710774076 - CDXC - A2AG5N (XNCM)
CHROMADEX CORP Share
5,56 USD
Current Prices from CHROMADEX CORP
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
NASDAQ |
CDXC
|
USD
|
24.12.2024 21:59
|
5,56 USD
| 5,30 USD | 4,91 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -2,46 % | -25,27 % | 47,09 % | 118,04 % | 283,45 % | 28,11 % |
Company Profile for CHROMADEX CORP Share
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Company Data for CHROMADEX CORP Share
Name CHROMADEX CORP
Company ChromaDex Corporation
Symbol CDXC
Website https://www.chromadex.com
Primary Exchange
NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Robert N. Fried
Market Capitalization 276 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 10900 Wilshire Boulevard, 90024 Los Angeles
IPO Date 2008-06-25
Stock Splits
Date | Split |
---|---|
13.04.2016 | 1:3 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | OCD1.F |
NASDAQ | CDXC |
More Shares
Investors who CHROMADEX CORP hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.